Research Organization
type: Class

Anualidad
type: Class

2020
type: Class

Research Activity Report
type: Class

RDF description of Optimización Biofarmacéutica y disolución biopredictiva 2020 - http://research.umh.es/vivo/pub/memoria/2020/gi_1020
type: Document
rights: termsOfUse
date: 2026-04-01T19:14:28
publisher: Optimización Biofarmacéutica y disolución biopredictiva 2020

Optimización Biofarmacéutica y disolución biopredictiva 2020
type: 2020
includes: SIMPOSIO ¿ ACTUALIZACIÓN EN EL MANEJO DE LOS PACIENTES CON ACIDEZ Y/O REFLUJO EN FARMACIA COMUNITARIA
includes: BERMEJO SANZ, MARIA DEL VAL
includes: Application of the Gastrointestinal Simulator (GIS) coupled with in silico modeling to measure the impact of Coca-Cola® on the luminal and systemic behavior of loratadine (BCS class 2b)
includes: Effectiveness of a Patient-Centered Weight Management Model in a Community Pharmacy: An Interventional Study
includes: Prescripción potencialmente inapropiada en pacientes con insuficiencia cardíaca. Intervención farmac��utica: revisión de la evidencia.
includes: Effect of thickener on disintegration, dissolution and permeability of common drug products for elderly patients
includes: UV1.19T
includes: 53KI1009VT
includes: Effect of Common Excipients on Intestinal Drug Absorption in Wistar Rats
includes: Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development
includes: KI1008IP
includes: Protocolo del estudio ES-REFLUJO: estudio epidemiológico de la acidez y reflujo gastroesofágico en farmacias comunitarias españolas
includes: Candesartan Cilexetil Two Step In Vitro-in Vivo Correlation (ivivc)
includes: In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions
includes: SAF2016-78756-P
includes: Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies
includes: Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
includes: In vivo predictive dissolution (IPD) for Carbamazepine formulations: Additional evidence regarding the universal biopredictive dissolution medium.
includes: Oral controlled release dosage forms: dissolution versus diffusion
includes: BE Discriminant In Vitro dissolution test for Two Ibuprofen Formulations: relevance of buffer strength and fluid volume.
includes: Biomimetic Artificial Membrane Permeability Assay over Franz Cell Apparatus Using BCS Model Drugs
includes: Effect of excipients on oral absorption process according to the different gastrointestinal segments
type: Research Activity Report
includes: Implantación de un servicio profesional farmacéutico asistencial integral de nutrición y optimización de la farmacoterapia en una farmacia comunitaria española
includes: AIMPLAS1.20T
relates: Optimización Biofarmacéutica y disolución biopredictiva
includes: Intervención del farmacéutico comunitario en atención domiciliaria: una revisión exploratoria
includes: con 128227.0
includes: Impact of patients¿ perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies
includes: Recent developments in cancer therapy and diagnosis
includes: Surfactant-Triggered Molecular Gate Tested on Different Mesoporous Silica Supports for Gastrointestinal Controlled Delivery
includes: KERNPHARMA1.20T
includes: IDENTIFICACIÓN DE UN PRM POREL USO PROLONGADO DE PREDNISONA
includes: Candesartan Cilexetil In Vitro-In Vivo Correlation: Predictive Dissolution as a Development Tool
includes: SANCHEZ DENGRA, BARBARA
includes: GONZALEZ ALVAREZ, MARTA
type: Anualidad
includes: Adherencia, persistencia y calidad de vida en pacientes con EPOC. Resultados del estudio observacional PREDAPER-EPOC en farmacias comunitarias españolas
includes: Modelización y tratamiento matemático de la epidemia COVID-19 en España hasta junio de 2020
includes: Manejo de la Plataforma ¿Sefac-Xpert¿: descripción de una experiencia formativa
most specific type: 2020
includes: Two-step in vitro-in vivo correlations: Deconvolution and convolution methods, which one gives the best predictability? Comparison with one-step approach
includes: Intervenciones desde la farmacia comunitaria en los pacientes adultos que reciben atención de la salud a domicilio: revisión exploratoria
includes: "Driving AMR action in a new decade"
includes: New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy
includes: Manejo de la plataforma SEFAC e_XPERT: descripción de una experiencia formativa
type: Research Organization
most specific type: Research Organization
included: Optimización Biofarmacéutica y disolución biopredictiva
includes: SYNTHON1.20A
includes: INFLUENCIA DE LOS EXCIPIENTES EN LA BIODISPONIBILIDAD ORAL
includes: Rol del framacéutico comunitario en el uso adecuado de antibióticos
type: Thing
includes: GONZALEZ ALVAREZ, MARIA ISABEL
includes: PACIENTE FRÁGIL, PACIENTE CRÓNICO: ¿CÓMO LO CUIDAMOS?
includes: Unraveling the behavior of oral drug products inside the human gastrointestinal tract using the aspiration technique: history, methodology and applications
includes: PBPK MODELING AND QUANTITATIVE STRUCTURE-PROPERTY RELATIONSHIPS TO PREDICT DRUG DELIVERY TO THE BRAIN
includes: WHO Biowaiver Study Project for COVID-19 Outbreak: Dexamethasone Solubility Results for Biopharmaceutical Classification System
includes: Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP
includes: con 128228.0
includes: BCS 1 in vivo BE failures: investigation with in vitro models: Dexketoprofen Trometamol

SIMPOSIO ¿ ACTUALIZACIÓN EN EL MANEJO DE LOS PACIENTES CON ACIDEZ Y/O REFLUJO EN FARMACIA COMUNITARIA
type: Anualidad
type: BFO_0000015
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000001
type: Event
type: Thing
type: 2020
type: InvitedConference
type: InvitedTalk
type: Presentation
type: BFO_0000003

BERMEJO SANZ, MARIA DEL VAL
type: PersonActive
type: Agent
type: BFO_0000001
type: Person
type: Thing
type: BFO_0000004
type: BFO_0000002
included: Optimización Biofarmacéutica y disolución biopredictiva 2020

Application of the Gastrointestinal Simulator (GIS) coupled with in silico modeling to measure the impact of Coca-Cola® on the luminal and systemic behavior of loratadine (BCS class 2b)
type: BFO_0000001
type: Article
type: Anualidad
type: BFO_0000002
type: 2020
type: Document
type: AcademicArticle
type: IAO_0000030
type: BFO_0000031
type: Thing
included: Optimización Biofarmacéutica y disolución biopredictiva 2020

Effectiveness of a Patient-Centered Weight Management Model in a Community Pharmacy: An Interventional Study
type: Thing
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Anualidad
type: BFO_0000002
type: IAO_0000030
type: AcademicArticle
type: 2020
type: BFO_0000031
type: BFO_0000001
type: Article
type: Document

Prescripción potencialmente inapropiada en pacientes con insuficiencia cardíaca. Intervención farmac��utica: revisión de la evidencia.
type: Conference
type: Anualidad
type: IAO_0000030
type: Document
type: Thing
type: BFO_0000002
type: ConferencePoster
type: BFO_0000001
type: BFO_0000031
type: 2020
included: Optimización Biofarmacéutica y disolución biopredictiva 2020

Effect of thickener on disintegration, dissolution and permeability of common drug products for elderly patients
type: Article
type: Document
type: BFO_0000031
type: Anualidad
type: AcademicArticle
type: BFO_0000002
type: BFO_0000001
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: IAO_0000030
type: 2020
type: Thing

UV1.19T
type: BFO_0000015
type: Relationship
type: Thing
type: Prestacion
type: ProyectoApoyoTecnologico
type: BFO_0000002
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: 2020
type: Grant
type: Proyecto
type: Year2019
type: BFO_0000001
type: BFO_0000020
type: Project
type: Anualidad
type: BFO_0000003

53KI1009VT
type: Anualidad
type: ProyectoInvestigacion
type: Grant
type: BFO_0000020
type: 2020
type: BFO_0000015
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Thing
type: BFO_0000003
type: BFO_0000002
type: ERO_0000014
type: BFO_0000001
type: Relationship
type: Project
type: Proyecto
type: OBI_0000011

Effect of Common Excipients on Intestinal Drug Absorption in Wistar Rats
type: Anualidad
type: BFO_0000002
type: IAO_0000030
type: Thing
type: BFO_0000001
type: Article
type: 2020
type: AcademicArticle
type: Document
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000031

Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development
type: 2020
type: Thing
type: IAO_0000030
type: BFO_0000001
type: AcademicArticle
type: BFO_0000002
type: Article
type: Document
type: BFO_0000031
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Anualidad

KI1008IP
type: BFO_0000015
type: 2020
type: Grant
type: BFO_0000020
type: BFO_0000003
type: BFO_0000002
type: Relationship
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000001
type: ERO_0000014
type: Year2021
type: ProyectoInvestigacion
type: Anualidad
type: Project
type: Proyecto
type: OBI_0000011
type: Thing

Protocolo del estudio ES-REFLUJO: estudio epidemiológico de la acidez y reflujo gastroesofágico en farmacias comunitarias españolas
type: BFO_0000001
type: Article
type: IAO_0000030
type: Anualidad
type: 2020
type: Thing
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000002
type: AcademicArticle
type: Document
type: BFO_0000031

Candesartan Cilexetil Two Step In Vitro-in Vivo Correlation (ivivc)
type: Thing
type: Anualidad
type: BFO_0000002
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000031
type: ConferencePoster
type: IAO_0000030
type: BFO_0000001
type: 2020
type: Document
type: Conference

In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions
type: BFO_0000002
type: BFO_0000001
type: 2020
type: Anualidad
type: IAO_0000030
type: AcademicArticle
type: Thing
type: Document
type: Article
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000031

SAF2016-78756-P
type: BFO_0000003
type: Year2021
type: Proyecto
type: Anualidad
type: OBI_0000011
type: Year2017
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Thing
type: ProyectoInvestigacion
type: Year2018
type: Grant
type: Year2019
type: 2020
type: BFO_0000020
type: BFO_0000001
type: BFO_0000015
type: ERO_0000014
type: Relationship
type: BFO_0000002
type: Project

Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies
type: Thing
type: Article
type: Anualidad
type: Document
type: BFO_0000002
type: BFO_0000031
type: IAO_0000030
type: AcademicArticle
type: BFO_0000001
type: 2020
included: Optimización Biofarmacéutica y disolución biopredictiva 2020

Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
type: BFO_0000002
type: BFO_0000001
type: AcademicArticle
type: Thing
type: Anualidad
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Document
type: BFO_0000031
type: 2020
type: IAO_0000030
type: Article

In vivo predictive dissolution (IPD) for Carbamazepine formulations: Additional evidence regarding the universal biopredictive dissolution medium.
type: IAO_0000030
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000001
type: BFO_0000031
type: Document
type: Thing
type: Anualidad
type: AcademicArticle
type: Article
type: 2020
type: BFO_0000002

Oral controlled release dosage forms: dissolution versus diffusion
type: BFO_0000002
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Thing
type: IAO_0000030
type: Article
type: Anualidad
type: 2020
type: Document
type: BFO_0000001
type: AcademicArticle
type: BFO_0000031

BE Discriminant In Vitro dissolution test for Two Ibuprofen Formulations: relevance of buffer strength and fluid volume.
type: BFO_0000001
type: BFO_0000031
type: IAO_0000030
type: Thing
type: BFO_0000002
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Anualidad
type: Document
type: ConferencePaper
type: 2020
type: Conference
type: Article

Biomimetic Artificial Membrane Permeability Assay over Franz Cell Apparatus Using BCS Model Drugs
type: BFO_0000002
type: Article
type: BFO_0000001
type: BFO_0000031
type: Document
type: AcademicArticle
type: IAO_0000030
type: Anualidad
type: Thing
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: 2020

Effect of excipients on oral absorption process according to the different gastrointestinal segments
type: 2020
type: Anualidad
type: Document
type: IAO_0000030
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000031
type: Article
type: Thing
type: AcademicArticle
type: BFO_0000002
type: BFO_0000001

Implantación de un servicio profesional farmacéutico asistencial integral de nutrición y optimización de la farmacoterapia en una farmacia comunitaria española
type: Article
type: BFO_0000002
type: Anualidad
type: Document
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000001
type: Thing
type: BFO_0000031
type: 2020
type: AcademicArticle
type: IAO_0000030

AIMPLAS1.20T
type: BFO_0000002
type: BFO_0000003
type: Relationship
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: ProyectoApoyoTecnologico
type: Thing
type: BFO_0000001
type: Grant
type: BFO_0000015
type: BFO_0000020
type: Proyecto
type: Project
type: Prestacion
type: 2020
type: Anualidad

Optimización Biofarmacéutica y disolución biopredictiva
type: BFO_0000002
type: Thing
type: ResearchOrganizationActive
related by: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: ResearchOrganization
type: BFO_0000001
type: Agent
type: BFO_0000004
type: Organization
includes: Optimización Biofarmacéutica y disolución biopredictiva 2020

Intervención del farmacéutico comunitario en atención domiciliaria: una revisión exploratoria
type: IAO_0000030
type: AcademicArticle
type: BFO_0000001
type: BFO_0000031
type: 2020
type: BFO_0000002
type: Article
type: Anualidad
type: Document
type: Thing
included: Optimización Biofarmacéutica y disolución biopredictiva 2020

Impact of patients¿ perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies
type: Anualidad
type: BFO_0000001
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Thing
type: BFO_0000002
type: AcademicArticle
type: Document
type: 2020
type: BFO_0000031
type: IAO_0000030
type: Article

Recent developments in cancer therapy and diagnosis
type: BFO_0000031
type: Document
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: 2020
type: BFO_0000002
type: IAO_0000030
type: AcademicArticle
type: Article
type: Anualidad
type: BFO_0000001
type: Thing

Protocolo del estudio ES-REFLUJO: estudio epidemiológico de la acidez y reflujo gastroesofágico en farmacias comunitarias españolas
type: Thing
type: IAO_0000030
type: BFO_0000002
type: Anualidad
type: Conference
type: Document
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: ConferencePoster
type: BFO_0000001
type: BFO_0000031
type: 2020

Surfactant-Triggered Molecular Gate Tested on Different Mesoporous Silica Supports for Gastrointestinal Controlled Delivery
type: 2020
type: Anualidad
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Thing
type: BFO_0000002
type: BFO_0000001
type: IAO_0000030
type: Article
type: AcademicArticle
type: BFO_0000031
type: Document

KERNPHARMA1.20T
type: Grant
type: BFO_0000003
type: BFO_0000002
type: Year2021
type: ProyectoApoyoTecnologico
type: BFO_0000015
type: Prestacion
type: Relationship
type: 2020
type: Project
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000020
type: Proyecto
type: Anualidad
type: Thing
type: BFO_0000001

IDENTIFICACIÓN DE UN PRM POREL USO PROLONGADO DE PREDNISONA
type: 2020
type: BFO_0000031
type: BFO_0000001
type: Document
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Chapter
type: BFO_0000002
type: DocumentPart
type: IAO_0000030
type: Anualidad
type: BookSection
type: Thing

Candesartan Cilexetil In Vitro-In Vivo Correlation: Predictive Dissolution as a Development Tool
type: BFO_0000002
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000001
type: Anualidad
type: AcademicArticle
type: BFO_0000031
type: Thing
type: Document
type: IAO_0000030
type: 2020
type: Article

SANCHEZ DENGRA, BARBARA
type: PersonActive
type: Agent
type: BFO_0000001
type: Person
type: Thing
type: BFO_0000004
type: BFO_0000002
included: Optimización Biofarmacéutica y disolución biopredictiva 2020

GONZALEZ ALVAREZ, MARTA
type: PersonActive
type: Agent
type: BFO_0000001
type: Person
type: Thing
type: BFO_0000004
type: BFO_0000002
included: Optimización Biofarmacéutica y disolución biopredictiva 2020

Adherencia, persistencia y calidad de vida en pacientes con EPOC. Resultados del estudio observacional PREDAPER-EPOC en farmacias comunitarias españolas
type: BFO_0000031
type: IAO_0000030
type: BFO_0000001
type: BFO_0000002
type: Article
type: 2020
type: Document
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Thing
type: AcademicArticle
type: Anualidad

Modelización y tratamiento matemático de la epidemia COVID-19 en España hasta junio de 2020
type: 2020
type: Thing
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: AcademicArticle
type: Article
type: BFO_0000031
type: Anualidad
type: BFO_0000001
type: Document
type: IAO_0000030
type: BFO_0000002

Manejo de la Plataforma ¿Sefac-Xpert¿: descripción de una experiencia formativa
type: Thing
type: ConferencePoster
type: Conference
type: Document
type: Anualidad
type: IAO_0000030
type: BFO_0000001
type: 2020
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000002
type: BFO_0000031

Two-step in vitro-in vivo correlations: Deconvolution and convolution methods, which one gives the best predictability? Comparison with one-step approach
type: Document
type: Thing
type: Article
type: 2020
type: Anualidad
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000031
type: BFO_0000002
type: AcademicArticle
type: BFO_0000001
type: IAO_0000030

Intervenciones desde la farmacia comunitaria en los pacientes adultos que reciben atención de la salud a domicilio: revisión exploratoria
type: IAO_0000030
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Article
type: 2020
type: Thing
type: BFO_0000002
type: Anualidad
type: AcademicArticle
type: BFO_0000031
type: Document
type: BFO_0000001

"Driving AMR action in a new decade"
type: BFO_0000003
type: 2020
type: Event
type: Anualidad
type: Thing
type: InvitedTalk
type: BFO_0000015
type: BFO_0000001
type: InvitedConference
type: Presentation
included: Optimización Biofarmacéutica y disolución biopredictiva 2020

Implantación de un servicio profesional farmacéutico asistencial integral de nutrición y optimización de la farmacoterapia en una farmacia comunitaria española
type: ConferencePoster
type: Anualidad
type: BFO_0000002
type: Conference
type: Thing
type: BFO_0000001
type: Document
type: 2020
type: BFO_0000031
type: IAO_0000030
included: Optimización Biofarmacéutica y disolución biopredictiva 2020

Adherencia, persistencia y calidad de vida en pacientes con EPOC. Resultados del estudio observacional PREDAPER-EPOC en farmacias comunitarias españolas
type: BFO_0000002
type: BFO_0000001
type: Document
type: 2020
type: BFO_0000031
type: Anualidad
type: Conference
type: Thing
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: ConferencePoster
type: IAO_0000030

New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy
type: 2020
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Anualidad
type: Thing
type: BFO_0000002
type: BFO_0000001
type: IAO_0000030
type: Article
type: AcademicArticle
type: BFO_0000031
type: Document

Manejo de la plataforma SEFAC e_XPERT: descripción de una experiencia formativa
type: 2020
type: BFO_0000002
type: AcademicArticle
type: Article
type: Document
type: BFO_0000031
type: IAO_0000030
type: BFO_0000001
type: Anualidad
type: Thing
included: Optimización Biofarmacéutica y disolución biopredictiva 2020

SYNTHON1.20A
type: Relationship
type: BFO_0000001
type: ProyectoApoyoTecnologico
type: Proyecto
type: Thing
type: BFO_0000020
type: Year2021
type: BFO_0000015
type: 2020
type: Grant
type: BFO_0000002
type: BFO_0000003
type: Prestacion
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Anualidad
type: Project

INFLUENCIA DE LOS EXCIPIENTES EN LA BIODISPONIBILIDAD ORAL
type: IAO_0000030
type: 2020
type: Document
type: TesisDoctoral
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Anualidad
type: BFO_0000001
type: Thesis
type: BFO_0000031
type: Thing
type: BFO_0000002

Rol del framacéutico comunitario en el uso adecuado de antibióticos
type: Event
type: InvitedConference
type: 2020
type: Presentation
type: InvitedTalk
type: BFO_0000003
type: Thing
type: BFO_0000015
type: BFO_0000001
type: Anualidad
included: Optimización Biofarmacéutica y disolución biopredictiva 2020

GONZALEZ ALVAREZ, MARIA ISABEL
type: PersonActive
type: Agent
type: BFO_0000001
type: Person
type: Thing
type: BFO_0000004
type: BFO_0000002
included: Optimización Biofarmacéutica y disolución biopredictiva 2020

PACIENTE FRÁGIL, PACIENTE CRÓNICO: ¿CÓMO LO CUIDAMOS?
type: BFO_0000015
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000003
type: Thing
type: Event
type: InvitedConference
type: 2020
type: BFO_0000001
type: Anualidad
type: Presentation
type: InvitedTalk

Unraveling the behavior of oral drug products inside the human gastrointestinal tract using the aspiration technique: history, methodology and applications
type: AcademicArticle
type: Anualidad
type: BFO_0000031
type: BFO_0000002
type: Document
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: 2020
type: IAO_0000030
type: BFO_0000001
type: Thing
type: Article

PBPK MODELING AND QUANTITATIVE STRUCTURE-PROPERTY RELATIONSHIPS TO PREDICT DRUG DELIVERY TO THE BRAIN
type: IAO_0000030
type: Anualidad
type: Thing
type: Article
type: ConferencePaper
type: Conference
type: Document
type: BFO_0000002
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: BFO_0000001
type: BFO_0000031
type: 2020

WHO Biowaiver Study Project for COVID-19 Outbreak: Dexamethasone Solubility Results for Biopharmaceutical Classification System
type: IAO_0000030
type: BFO_0000001
type: BFO_0000031
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Thing
type: Anualidad
type: Document
type: AcademicArticle
type: Article
type: 2020
type: BFO_0000002

Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP
type: 2020
type: BFO_0000002
type: Document
type: Thing
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: AcademicArticle
type: Article
type: BFO_0000031
type: Anualidad
type: IAO_0000030
type: BFO_0000001

BCS 1 in vivo BE failures: investigation with in vitro models: Dexketoprofen Trometamol
type: 2020
type: BFO_0000031
type: Article
type: ConferencePaper
type: BFO_0000002
type: Conference
type: BFO_0000001
type: Thing
type: Anualidad
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: IAO_0000030
type: Document

Intervención del farmacéutico comunitario en atención domiciliaria: una revisión exploratoria
type: Anualidad
type: Article
type: BFO_0000002
type: BFO_0000031
type: IAO_0000030
included: Optimización Biofarmacéutica y disolución biopredictiva 2020
type: Document
type: ConferencePaper
type: Thing
type: Conference
type: BFO_0000001
type: 2020